Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hypercalcemia AND malignant neoplasms AND morbidity - disease rate AND mortality vital statistics:

Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma. Qu Q et al. Am Surg. (2014)

Quality and Outcomes of Treatment of Hypercalcemia of Malignancy. Wright JD et al. Cancer Invest. (2015)

Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. Vellanki P et al. J Clin Endocrinol Metab. (2014)

Search results

Items: 1 to 20 of 118

  • The following term was ignored: -
  • See the search details.
1.

[Parathyroid cancer].

Ságová I, Stančík M, Kentoš P, Pavai D, Kantárová D, Vaňuga A, Vaňuga P.

Vnitr Lek. Winter 2017;63(2):139-144. Czech.

PMID:
28334546
2.

Genital vasculitis secondary to all-trans-retinoic-acid.

Yanamandra U, Khadwal A, Saikia UN, Malhotra P.

BMJ Case Rep. 2016 Jan 20;2016. pii: bcr2015212205. doi: 10.1136/bcr-2015-212205.

PMID:
26791116
3.

Parathyroid Carcinoma: Diagnosis and Clinical Implications.

Duan K, Mete Ö.

Turk Patoloji Derg. 2015;31 Suppl 1:80-97. doi: 10.5146/tjpath.2015.01316. Review.

4.

Quality and Outcomes of Treatment of Hypercalcemia of Malignancy.

Wright JD, Tergas AI, Ananth CV, Burke WM, Hou JY, Chen L, Neugut AI, Richards CA, Hershman DL.

Cancer Invest. 2015;33(8):331-9. doi: 10.3109/07357907.2015.1047506. Epub 2015 Jun 12.

5.

Nanoparticles-Based Treatment for Bone Metastasis.

Saracino R, Luciano R, Battafarano G, Perrotta A, Muraca M, Del Fattore A.

Curr Drug Targets. 2016;17(3):303-10. Review.

PMID:
25915486
6.

Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records.

Shephard EA, Neal RD, Rose P, Walter FM, Litt EJ, Hamilton WT.

Br J Gen Pract. 2015 Feb;65(631):e106-13. doi: 10.3399/bjgp15X683545.

7.

Primary hyperparathyroidism during pregnancy.

Dochez V, Ducarme G.

Arch Gynecol Obstet. 2015 Feb;291(2):259-63. doi: 10.1007/s00404-014-3526-8. Epub 2014 Nov 4. Review.

PMID:
25367603
8.

Burden of skeletal-related events in prostate cancer: unmet need in pain improvement.

Broder MS, Gutierrez B, Cherepanov D, Linhares Y.

Support Care Cancer. 2015 Jan;23(1):237-47. doi: 10.1007/s00520-014-2437-3. Epub 2014 Oct 2. Review.

PMID:
25270847
9.

Renal Insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement.

Park S, Han B, Kim K, Kim SJ, Jang JH, Kim WS, Jung CW.

Anticancer Res. 2014 Aug;34(8):4299-306.

PMID:
25075062
10.

Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma.

Highsmith KN, Chen SE, Horowitz S.

Pharmacotherapy. 2014 Sep;34(9):927-40. doi: 10.1002/phar.1463. Epub 2014 Jul 19. Review.

PMID:
25044413
11.

Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.

Kamp K, Feelders RA, van Adrichem RC, de Rijke YB, van Nederveen FH, Kwekkeboom DJ, de Herder WW.

J Clin Endocrinol Metab. 2014 Sep;99(9):3060-9. doi: 10.1210/jc.2014-1315. Epub 2014 Jun 6.

PMID:
24905065
12.

Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.

Karuppiah D, Thanabalasingham G, Shine B, Wang LM, Sadler GP, Karavitaki N, Grossman AB.

Eur J Endocrinol. 2014 Jul;171(1):K1-5. doi: 10.1530/EJE-14-0166. Epub 2014 Apr 17.

13.

Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners.

Quinn RH, Randall RL, Benevenia J, Berven SH, Raskin KA.

Instr Course Lect. 2014;63:431-41.

PMID:
24720328
14.

Medical treatment of breast cancer bone metastasis: from bisphosphonates to targeted drugs.

Erdogan B, Cicin I.

Asian Pac J Cancer Prev. 2014;15(4):1503-10. Review.

15.

Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.

Qu Q, Wang S, Chen S, Zhou L, Rui JA.

Am Surg. 2014 Feb;80(2):191-6.

PMID:
24480222
16.

Multiple myeloma and kidney disease.

Katagiri D, Noiri E, Hinoshita F.

ScientificWorldJournal. 2013 Oct 27;2013:487285. doi: 10.1155/2013/487285. eCollection 2013. Review.

17.

Characteristics, treatment and prognostic factors of patients with gynaecological malignancies treated in a palliative care unit at a university hospital.

Aeckerle S, Moor M, Pilz LR, Gencer D, Hofheinz RD, Hofmann WK, Buchheidt D.

Onkologie. 2013;36(11):642-8. doi: 10.1159/000355642. Epub 2013 Oct 18.

18.

Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.

Vellanki P, Lange K, Elaraj D, Kopp PA, El Muayed M.

J Clin Endocrinol Metab. 2014 Feb;99(2):387-90. doi: 10.1210/jc.2013-3031. Epub 2013 Oct 31.

19.

Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma.

Smidt-Hansen T, Folkmar TB, Fode K, Agerbaek M, Donskov F.

J Oral Maxillofac Surg. 2013 Sep;71(9):1532-40. doi: 10.1016/j.joms.2013.03.019. Epub 2013 May 1.

PMID:
23642545
20.

New and emerging therapies for bone metastases in genitourinary cancers.

Saylor PJ, Armstrong AJ, Fizazi K, Freedland S, Saad F, Smith MR, Tombal B, Pienta K.

Eur Urol. 2013 Feb;63(2):309-20. doi: 10.1016/j.eururo.2012.10.007. Epub 2012 Nov 23. Review.

Supplemental Content

Loading ...
Support Center